An international team of researchers from the United States, Denmark and Sweden has pioneered a new approach that brings an oral formulation of insulin that can be swallowed rather than injected one step closer to the clinic. The scientists have developed an ingestible microneedle that can inject insulin into the stomach lining in a large animal model. They have also demonstrated that their tiny pill — about the size of a blueberry — can...